PPTA Twitter

PlasmaProteins #PlasmaProtein therapies are high-impact treatments because they increase life-expectancy, improve quality of life, and reduce life-threatening complications for people living with plasma protein deficiencies. Learn more about PPTs’ unique qualities: bit.ly/2QF6N1B
About 19 hours ago.
PlasmaProteins For Chris, access to #plasmaprotein therapies means that he, and his daughter Allyson, have the therapy they need to treat their #hemophilia . Read how PPTs allow them to continuously enjoy their daily adventures. #FathersDay . bit.ly/2DzFQ9X pic.twitter.com/T5zsYoUEo3
1 day ago.

Plasma Protein Therapeutics Association

The Plasma Protein Therapeutics Association (PPTA) represents the private sector manufacturers of plasma-derived and recombinant analog therapies, collectively known as plasma protein therapies and the collectors of source plasma used for fractionation. These therapies are used by small patient populations worldwide to treat a variety of rare diseases and serious medical conditions.

Erica XLA

PPTA works globally to:

    • Advocate for access to and affordability of therapies for patients
    • Engage in constructive dialogue with regulatory agencies
    • Collaborate with patient advocacy organizations

PPTA also administers standards and programs that help ensure the quality and safety of plasma collection and manufacturing and protect both donors and patients.

Copyright © 2018 PPTA. All rights reserved. (202) 789-3100